Brain Cancer Zapper Web Extra

Clinical trials at a dozen major hospitals around the country are now testing a cutting-edge experimental therapy against the most common and aggressive type of brain tumor, glioblastoma multiforme. This video contains extended interview clips from a patient and doctor involved in the trial, as a supplement to the ScienCentral News story, "Brain Cancer Zapper."

Participant Michael Quatrano and principal investigator Herb Engelhard at the University of Illinois-Chicago Medical Center talk more about the disease and the experimental treatment.

This material is made possible by the Proceedings of the National Academy of Sciences and the National Academies.

"Michael and the other patients that are participating in this study are very brave individuals-- they're pioneers," Engelhard says. "I give a lot of credit to them; it's not easy, and they're fighting a very bad, very, very bad disease… And sometimes it can be difficult to participate in these experimental therapies, but it's certainly worth it."